• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207

6-Chloro-2,4-dimethylnicotinic acid hydrochloride: A Comprehensive Overview

The compound 6-Chloro-2,4-dimethylnicotinic acid hydrochloride (CAS No. 871493-00-4) is a notable chemical entity with significant applications in the pharmaceutical and chemical industries. This compound belongs to the class of nicotinic acids, which are derivatives of nicotinic acid, a well-known precursor to niacin (vitamin B3). The presence of chlorine and methyl groups in its structure introduces unique chemical and biological properties that make it a subject of interest for researchers and industry professionals alike.

6-Chloro-2,4-dimethylnicotinic acid hydrochloride is synthesized through a series of well-established organic synthesis techniques. The synthesis involves the introduction of chlorine and methyl groups at specific positions on the nicotinic acid backbone. This process ensures the compound's stability and bioavailability, making it suitable for various applications. Recent advancements in synthetic chemistry have further optimized the production process, reducing costs and improving yield.

The structural features of 6-Chloro-2,4-dimethylnicotinic acid hydrochloride play a crucial role in its pharmacological activity. The chlorine atom at position 6 and the methyl groups at positions 2 and 4 contribute to its lipophilicity, enhancing its ability to cross biological membranes. This property is particularly advantageous in drug design, where membrane permeability is a critical factor for bioavailability.

Recent studies have highlighted the potential of 6-Chloro-2,4-dimethylnicotinic acid hydrochloride as a lead compound in the development of novel therapeutic agents. Researchers have explored its role in modulating cellular signaling pathways, particularly those involved in inflammation and oxidative stress. These findings suggest that the compound may have applications in treating conditions such as neurodegenerative diseases, cardiovascular disorders, and certain types of cancer.

In addition to its pharmacological applications, 6-Chloro-2,4-dimethylnicotinic acid hydrochloride has also found use in agrochemicals and industrial chemistry. Its ability to inhibit specific enzymes makes it a promising candidate for pest control agents and industrial catalysts. Ongoing research is focused on optimizing its stability under various environmental conditions to expand its utility further.

The commercial availability of 6-Chloro-2,4-dimethylnicotinic acid hydrochloride has been supported by its favorable safety profile. Preclinical studies indicate that it exhibits low toxicity at therapeutic doses, making it a safer option compared to some other nicotinic acid derivatives. This safety profile has been instrumental in advancing its development for human use.

In conclusion, 6-Chloro-2,4-dimethylnicotinic acid hydrochloride (CAS No. 871493-00-4) is a versatile compound with diverse applications across multiple industries. Its unique chemical structure, coupled with recent advancements in synthesis and pharmacology, positions it as a valuable asset in both research and commercial settings. As ongoing studies continue to uncover new insights into its properties and potential uses, this compound is poised to make significant contributions to the fields of medicine and beyond.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)